Skip to content

TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)

TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01043354
Acronym
TACTICS
Enrollment
247
Registered
2010-01-06
Start date
2008-09-30
Completion date
2012-06-30
Last updated
2014-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Keywords

cholesterol, diabetes, adherence

Brief summary

Background: This is a randomized controlled trial (RCT) of two novel behavioral interventions to enhance treatment adherence and improve low-density lipoprotein cholesterol (LDL) in diabetes. Among adults with diabetes, high LDL greatly increases their risk for cardiovascular disease (CVD). Despite the proven efficacy of LDL control(\<100 mg/dL) in preventing CVD, the control rate is low. Poor adherence to treatment(diet, exercise and medication) is the main reason for this poor control. Aims: This study will test two telephone-delivered interventions, a Transtheoretical stage-matched intervention (SMI) and a Prospect theory-based framing effects intervention (FEI). The investigators hypothesize that both SMI and FEI will be more effective in improving LDL control than an attention placebo intervention (API) at 6 months. SMI and FEI will also be more effective in increasing adherence to medications, diet and exercise than API at 6 months. Methods: The investigators will recruit 246 adults with diabetes and high LDL despite being on medications. Key outcomes are adherence to diet, exercise and medication, and LDL control. The interventions will be standardized and fidelity of intervention maintained. Using a blinded RCT the investigators will test the effect of SMI and FEI compared to API on LDL control and adherence. All analyses will be intent to treat. Significance: This project will provide important information to improve diabetes-related behavior and lead to the implementation of novel interventions for lowering LDL in primary care settings among adults with diabetes. It may also provide the scientific rationale to use such approaches to control other risk factors in diabetes.

Interventions

BEHAVIORALstage-matched intervention

6 monthly tailored telephone-delivered counseling sessions of transtheoretical model-based counseling

BEHAVIORALframing effects intervention

6 monthly telephone-delivered counseling sessions based on prospect theory

BEHAVIORALattention placebo intervention

6 monthly counseling sessions about general health topics

Sponsors

Narrows Institute for Biomedical Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with diabetes * LDL greater than or equal to 100 * Cholesterol-lowering drug therapy for \> 6 months * A working telephone * At least 2 primary care visits in the past 1.5 years

Exclusion criteria

* Poor short-term survival (\< 1 year) * Inability to understand English * Recent major surgery (\< 3 months) * Patients temporarily in the area * Inability to provide consent

Design outcomes

Primary

MeasureTime frame
LDL control6 months
medication adherence6 months

Secondary

MeasureTime frame
diet adherence6 months
exercise adherence6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026